{"doi":"10.1136/jitc-2024-008950","title":"High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC","abstract":"INTRODUCTION: Despite significant successes, immune checkpoint blockade fails to achieve clinical responses in a significant proportion of patients, predictive markers for responses are imperfect and immune-related adverse events (irAEs) are unpredictable. We used T-cell receptor (TCR) sequencing to systematically analyze prospectively collected patient blood samples from a randomized clinical trial of dual immune checkpoint inhibitor therapy to evaluate changes in the T-cell repertoire and their association with response and irAEs. METHODS: Patients with immunotherapy-naïve metastatic non-small cell lung cancer (NSCLC) were treated with ipilimumab and nivolumab according to trial protocol (LONESTAR, NCT03391869). Blood samples were systematically obtained at baseline (n=107), after 12 weeks of ipilimumab and nivolumab (n=91), and at the time of grade ≥2 irAEs (n=77). For analysis of T-cell repertoire, we performed immunoSEQ to assess the complementary determining region 3β region of the TCR involved in antigen binding. RESULTS: A total of 250 samples from 119 patients were analyzed. Patients who had a response to therapy exhibited greater T-cell diversity at baseline. Interestingly, patients with irAEs demonstrated lower T-cell richness at the time of toxicity compared with those without irAEs. CONCLUSION: Our study highlights the potential impact of peripheral blood T-cell repertoire on clinical response and toxicities from the combination of ipilimumab and nivolumab in patients with metastatic NSCLC. These findings suggest that analysis of peripheral blood T-cell repertoire may help to guide patient selection for treatment with ipilimumab and nivolumab. TRIAL REGISTRATION NUMBER: NCT03391869.","journal":"Journal for ImmunoTherapy of Cancer","year":2024,"id":434537,"datarank":0.514822218620352,"base_score":2.639057329615259,"endowment":2.639057329615259,"self_citation_contribution":0.3958585994422889,"citation_network_contribution":0.11896361917806314,"self_endowment_contribution":0.3958585994422889,"citer_contribution":0.11896361917806314,"corpus_percentile":null,"corpus_rank":null,"citation_count":13,"citer_count":12,"citers_with_citation_signal":8,"citers_with_endowment":8,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9567,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT03391869"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":684501,"name":"Ruoxing Li","orcid":"0000-0002-6660-1672","position":1,"is_corresponding":false},{"id":1028224,"name":"Ziyi Li","orcid":"0000-0003-0947-9137","position":2,"is_corresponding":false},{"id":247602,"name":"Runzhe Chen","orcid":"0000-0003-3834-2156","position":3,"is_corresponding":false},{"id":582400,"name":"Ajay Sheshadri","orcid":"0000-0002-8091-0180","position":4,"is_corresponding":false},{"id":247606,"name":"Hai T. Tran","orcid":"0000-0003-4065-9355","position":5,"is_corresponding":false},{"id":230398,"name":"Latasha Little","orcid":"0000-0001-9690-6314","position":6,"is_corresponding":false},{"id":1241826,"name":"Joshua Baguley","orcid":null,"position":7,"is_corresponding":false},{"id":1170508,"name":"Jefferson Sinson","orcid":null,"position":8,"is_corresponding":false},{"id":4544,"name":"Natalie I. Vokes","orcid":"0000-0002-3766-5335","position":9,"is_corresponding":false},{"id":397917,"name":"Saumil Gandhi","orcid":"0000-0002-3349-3521","position":10,"is_corresponding":false},{"id":355314,"name":"Mara B. Antonoff","orcid":"0000-0001-6247-9537","position":11,"is_corresponding":false},{"id":227933,"name":"Stephen G. Swisher","orcid":"0000-0002-3080-1920","position":12,"is_corresponding":false},{"id":395091,"name":"Gregory Lizée","orcid":"0000-0003-4449-7461","position":13,"is_corresponding":false},{"id":90418,"name":"Alexandre Reuben","orcid":"0000-0003-4510-0382","position":14,"is_corresponding":false},{"id":227923,"name":"John V. Heymach","orcid":"0000-0001-9068-8942","position":15,"is_corresponding":false},{"id":5677,"name":"Jianjun Zhang","orcid":"0000-0001-7872-3477","position":16,"is_corresponding":false},{"id":236012,"name":"Mehmet Altan","orcid":"0000-0001-9229-156X","position":0,"is_corresponding":true}],"reference_count":41,"raw_metadata":null,"created_at":"2026-07-19T01:59:58.582186Z","pmid":"39721752","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}